TNF and acute promyelocytic leukemia: The A-vitamin derivate all-trans retinoic acid (ATRA), used in the treatment of acute promyelocytic leukemia (APL), has previously been shown to upregulate M-Sec at the mRNA level alone and in combination with tumor necrosis factor α (TNFα) [35].